As of April 11, 2026, BioAge Labs's top three insider holders are Vijay Satyanand Pande (Director, 2.11Mn shares), Asset Management, Lp Cormorant (Other, 1.63Mn shares), Vijay Satyanand Pande (Director, 1.12Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Vijay Satyanand Pande | - | 0 | 2,113,975 | 27 Sep, 2024 |
| Asset Management, Lp Cormorant | - | 0 | 1,629,529 | 01 Oct, 2024 |
| Vijay Satyanand Pande | - | 0 | 1,119,195 | 03 Oct, 2024 |
| Kristen Fortney | Chief Executive Officer | 976,949 | 0 | 15 Jan, 2026 |
| Dov A Md Goldstein | Chief Financial Officer | 33,033 | 0 | 03 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Paul D Rubin | Common Stock | A | 5,437 | $4.11 | 5,437 | D | M |
| 01 Apr, 2026 | Paul D Rubin | Common Stock | A | 3,383 | $6.57 | 8,820 | D | M |
| 01 Apr, 2026 | Paul D Rubin | Common Stock | D | 8,820 | $17.81 | 0 | D | S |
| 01 Apr, 2026 | Paul D Rubin | Stock Option (Right to Buy) | D | 5,437 | $0.00 | 0 | D | M |
| 01 Apr, 2026 | Paul D Rubin | Stock Option (Right to Buy) | D | 3,383 | $0.00 | 0 | D | M |
| 02 Mar, 2026 | Paul D Rubin | Common Stock | A | 5,433 | $4.11 | 5,433 | D | M |
| 01 Mar, 2026 | Dov A Md Goldstein | Common Stock | A | 3,542 | $4.38 | 33,033 | D | M |
| 01 Mar, 2026 | Dov A Md Goldstein | Stock Option (Right to Buy) | D | 3,542 | $0.00 | 159,375 | D | M |
| 02 Mar, 2026 | Paul D Rubin | Common Stock | A | 2,000 | $6.57 | 7,433 | D | M |
| 02 Mar, 2026 | Paul D Rubin | Common Stock | D | 7,433 | $20.30 | 0 | D | S |
| 02 Mar, 2026 | Paul D Rubin | Stock Option (Right to Buy) | D | 5,433 | $0.00 | 5,437 | D | M |
| 02 Mar, 2026 | Paul D Rubin | Stock Option (Right to Buy) | D | 2,000 | $0.00 | 3,383 | D | M |
| 17 Feb, 2026 | Eric Morgen | Stock Option (Right to Buy) | A | 110,000 | $0.00 | 110,000 | D | A |
| 17 Feb, 2026 | Dov A Md Goldstein | Stock Option (Right to Buy) | A | 110,000 | $0.00 | 110,000 | D | A |
| 17 Feb, 2026 | Paul D Rubin | Stock Option (Right to Buy) | A | 110,000 | $0.00 | 110,000 | D | A |
| 17 Feb, 2026 | Shane Barton | Stock Option (Right to Buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 17 Feb, 2026 | Kristen Fortney | Stock Option (Right to Buy) | A | 330,000 | $0.00 | 330,000 | D | A |
| 17 Feb, 2026 | Eric Morgen | Stock Option (Right to Buy) | A | 12,500 | $0.00 | 12,500 | I | A |
| 01 Feb, 2026 | Dov A Md Goldstein | Common Stock | A | 3,541 | $4.38 | 29,491 | D | M |
| 02 Feb, 2026 | Paul D Rubin | Common Stock | A | 5,433 | $4.11 | 5,433 | D | M |